nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—Non-cardiac chest pain—Docetaxel—head and neck cancer	0.0449	0.0449	CcSEcCtD
Tadalafil—Angina unstable—Docetaxel—head and neck cancer	0.0308	0.0308	CcSEcCtD
Tadalafil—Lacrimation—Fluorouracil—head and neck cancer	0.0184	0.0184	CcSEcCtD
Tadalafil—Rectal haemorrhage—Vinblastine—head and neck cancer	0.0182	0.0182	CcSEcCtD
Tadalafil—Deafness—Vinblastine—head and neck cancer	0.0133	0.0133	CcSEcCtD
Tadalafil—Lacrimation—Docetaxel—head and neck cancer	0.0133	0.0133	CcSEcCtD
Tadalafil—Cerebrovascular accident—Vinblastine—head and neck cancer	0.0122	0.0122	CcSEcCtD
Tadalafil—Lacrimation increased—Fluorouracil—head and neck cancer	0.0117	0.0117	CcSEcCtD
Tadalafil—Face oedema—Hydroxyurea—head and neck cancer	0.0105	0.0105	CcSEcCtD
Tadalafil—Scotoma—Docetaxel—head and neck cancer	0.0103	0.0103	CcSEcCtD
Tadalafil—Angina pectoris—Vinblastine—head and neck cancer	0.0101	0.0101	CcSEcCtD
Tadalafil—Oesophagitis—Fluorouracil—head and neck cancer	0.00986	0.00986	CcSEcCtD
Tadalafil—Breast disorder—Hydroxyurea—head and neck cancer	0.00984	0.00984	CcSEcCtD
Tadalafil—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00907	0.00907	CcSEcCtD
Tadalafil—Myocardial infarction—Vinblastine—head and neck cancer	0.00902	0.00902	CcSEcCtD
Tadalafil—Swelling—Fluorouracil—head and neck cancer	0.00888	0.00888	CcSEcCtD
Tadalafil—Bone disorder—Docetaxel—head and neck cancer	0.00863	0.00863	CcSEcCtD
Tadalafil—Lacrimation increased—Docetaxel—head and neck cancer	0.00846	0.00846	CcSEcCtD
Tadalafil—Infestation NOS—Hydroxyurea—head and neck cancer	0.00839	0.00839	CcSEcCtD
Tadalafil—Infestation—Hydroxyurea—head and neck cancer	0.00839	0.00839	CcSEcCtD
Tadalafil—Amnesia—Fluorouracil—head and neck cancer	0.00834	0.00834	CcSEcCtD
Tadalafil—Haemoglobin—Vinblastine—head and neck cancer	0.0083	0.0083	CcSEcCtD
Tadalafil—Haemorrhage—Vinblastine—head and neck cancer	0.00826	0.00826	CcSEcCtD
Tadalafil—Hypoaesthesia—Vinblastine—head and neck cancer	0.00822	0.00822	CcSEcCtD
Tadalafil—Pharyngitis—Vinblastine—head and neck cancer	0.0082	0.0082	CcSEcCtD
Tadalafil—Hearing impaired—Docetaxel—head and neck cancer	0.00819	0.00819	CcSEcCtD
Tadalafil—Haemoglobin—Hydroxyurea—head and neck cancer	0.00757	0.00757	CcSEcCtD
Tadalafil—Haemorrhage—Hydroxyurea—head and neck cancer	0.00753	0.00753	CcSEcCtD
Tadalafil—Oesophagitis—Docetaxel—head and neck cancer	0.00712	0.00712	CcSEcCtD
Tadalafil—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00701	0.00701	CcSEcCtD
Tadalafil—Angiopathy—Hydroxyurea—head and neck cancer	0.00683	0.00683	CcSEcCtD
Tadalafil—Dysphagia—Fluorouracil—head and neck cancer	0.00677	0.00677	CcSEcCtD
Tadalafil—Angina pectoris—Fluorouracil—head and neck cancer	0.0066	0.0066	CcSEcCtD
Tadalafil—Vertigo—Vinblastine—head and neck cancer	0.00646	0.00646	CcSEcCtD
Tadalafil—Swelling—Docetaxel—head and neck cancer	0.00641	0.00641	CcSEcCtD
Tadalafil—Deafness—Docetaxel—head and neck cancer	0.00632	0.00632	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.0063	0.0063	CcSEcCtD
Tadalafil—Convulsion—Vinblastine—head and neck cancer	0.00623	0.00623	CcSEcCtD
Tadalafil—Hypertension—Vinblastine—head and neck cancer	0.00621	0.00621	CcSEcCtD
Tadalafil—Discomfort—Vinblastine—head and neck cancer	0.00605	0.00605	CcSEcCtD
Tadalafil—Hot flush—Docetaxel—head and neck cancer	0.00605	0.00605	CcSEcCtD
Tadalafil—Infestation NOS—Fluorouracil—head and neck cancer	0.00604	0.00604	CcSEcCtD
Tadalafil—Infestation—Fluorouracil—head and neck cancer	0.00604	0.00604	CcSEcCtD
Tadalafil—Menopausal symptoms—Docetaxel—head and neck cancer	0.00599	0.00599	CcSEcCtD
Tadalafil—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00595	0.00595	CcSEcCtD
Tadalafil—Renal impairment—Docetaxel—head and neck cancer	0.00594	0.00594	CcSEcCtD
Tadalafil—Myocardial infarction—Fluorouracil—head and neck cancer	0.00592	0.00592	CcSEcCtD
Tadalafil—Conjunctivitis—Fluorouracil—head and neck cancer	0.00587	0.00587	CcSEcCtD
Tadalafil—Urinary tract infection—Fluorouracil—head and neck cancer	0.00587	0.00587	CcSEcCtD
Tadalafil—Epistaxis—Fluorouracil—head and neck cancer	0.0057	0.0057	CcSEcCtD
Tadalafil—Convulsion—Hydroxyurea—head and neck cancer	0.00568	0.00568	CcSEcCtD
Tadalafil—Pain in extremity—Docetaxel—head and neck cancer	0.00566	0.00566	CcSEcCtD
Tadalafil—Migraine—Docetaxel—head and neck cancer	0.00557	0.00557	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00554	0.00554	CcSEcCtD
Tadalafil—Discomfort—Hydroxyurea—head and neck cancer	0.00552	0.00552	CcSEcCtD
Tadalafil—Haemoglobin—Fluorouracil—head and neck cancer	0.00545	0.00545	CcSEcCtD
Tadalafil—Rhinitis—Fluorouracil—head and neck cancer	0.00544	0.00544	CcSEcCtD
Tadalafil—Haemorrhage—Fluorouracil—head and neck cancer	0.00542	0.00542	CcSEcCtD
Tadalafil—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00539	0.00539	CcSEcCtD
Tadalafil—Pharyngitis—Fluorouracil—head and neck cancer	0.00538	0.00538	CcSEcCtD
Tadalafil—Oedema—Hydroxyurea—head and neck cancer	0.00535	0.00535	CcSEcCtD
Tadalafil—Infection—Hydroxyurea—head and neck cancer	0.00532	0.00532	CcSEcCtD
Tadalafil—Paraesthesia—Vinblastine—head and neck cancer	0.00527	0.00527	CcSEcCtD
Tadalafil—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00525	0.00525	CcSEcCtD
Tadalafil—Liver function test abnormal—Docetaxel—head and neck cancer	0.00522	0.00522	CcSEcCtD
Tadalafil—Skin disorder—Hydroxyurea—head and neck cancer	0.0052	0.0052	CcSEcCtD
Tadalafil—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00517	0.00517	CcSEcCtD
Tadalafil—Abdominal pain upper—Docetaxel—head and neck cancer	0.00517	0.00517	CcSEcCtD
Tadalafil—Breast disorder—Docetaxel—head and neck cancer	0.00511	0.00511	CcSEcCtD
Tadalafil—Nasopharyngitis—Docetaxel—head and neck cancer	0.00506	0.00506	CcSEcCtD
Tadalafil—Constipation—Vinblastine—head and neck cancer	0.00502	0.00502	CcSEcCtD
Tadalafil—Pain—Vinblastine—head and neck cancer	0.00502	0.00502	CcSEcCtD
Tadalafil—Dysphagia—Docetaxel—head and neck cancer	0.00489	0.00489	CcSEcCtD
Tadalafil—Gastrointestinal pain—Vinblastine—head and neck cancer	0.0048	0.0048	CcSEcCtD
Tadalafil—Dyspnoea—Hydroxyurea—head and neck cancer	0.00477	0.00477	CcSEcCtD
Tadalafil—Angina pectoris—Docetaxel—head and neck cancer	0.00476	0.00476	CcSEcCtD
Tadalafil—Somnolence—Hydroxyurea—head and neck cancer	0.00476	0.00476	CcSEcCtD
Tadalafil—Dyspepsia—Hydroxyurea—head and neck cancer	0.00471	0.00471	CcSEcCtD
Tadalafil—Abdominal pain—Vinblastine—head and neck cancer	0.00464	0.00464	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00462	0.00462	CcSEcCtD
Tadalafil—Fatigue—Hydroxyurea—head and neck cancer	0.00461	0.00461	CcSEcCtD
Tadalafil—Constipation—Hydroxyurea—head and neck cancer	0.00458	0.00458	CcSEcCtD
Tadalafil—Pain—Hydroxyurea—head and neck cancer	0.00458	0.00458	CcSEcCtD
Tadalafil—Vision blurred—Fluorouracil—head and neck cancer	0.00445	0.00445	CcSEcCtD
Tadalafil—Infestation NOS—Docetaxel—head and neck cancer	0.00436	0.00436	CcSEcCtD
Tadalafil—Infestation—Docetaxel—head and neck cancer	0.00436	0.00436	CcSEcCtD
Tadalafil—Hypersensitivity—Vinblastine—head and neck cancer	0.00432	0.00432	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00432	0.00432	CcSEcCtD
Tadalafil—Acute coronary syndrome—Docetaxel—head and neck cancer	0.0043	0.0043	CcSEcCtD
Tadalafil—Renal failure—Docetaxel—head and neck cancer	0.00428	0.00428	CcSEcCtD
Tadalafil—Myocardial infarction—Docetaxel—head and neck cancer	0.00427	0.00427	CcSEcCtD
Tadalafil—Conjunctivitis—Docetaxel—head and neck cancer	0.00424	0.00424	CcSEcCtD
Tadalafil—Asthenia—Vinblastine—head and neck cancer	0.00421	0.00421	CcSEcCtD
Tadalafil—Epistaxis—Docetaxel—head and neck cancer	0.00411	0.00411	CcSEcCtD
Tadalafil—Convulsion—Fluorouracil—head and neck cancer	0.00409	0.00409	CcSEcCtD
Tadalafil—Chest pain—Fluorouracil—head and neck cancer	0.00402	0.00402	CcSEcCtD
Tadalafil—Myalgia—Fluorouracil—head and neck cancer	0.00402	0.00402	CcSEcCtD
Tadalafil—Diarrhoea—Vinblastine—head and neck cancer	0.00401	0.00401	CcSEcCtD
Tadalafil—Discomfort—Fluorouracil—head and neck cancer	0.00397	0.00397	CcSEcCtD
Tadalafil—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00394	0.00394	CcSEcCtD
Tadalafil—Haemoglobin—Docetaxel—head and neck cancer	0.00393	0.00393	CcSEcCtD
Tadalafil—Rhinitis—Docetaxel—head and neck cancer	0.00392	0.00392	CcSEcCtD
Tadalafil—Haemorrhage—Docetaxel—head and neck cancer	0.00391	0.00391	CcSEcCtD
Tadalafil—Hypoaesthesia—Docetaxel—head and neck cancer	0.00389	0.00389	CcSEcCtD
Tadalafil—Pharyngitis—Docetaxel—head and neck cancer	0.00388	0.00388	CcSEcCtD
Tadalafil—Dizziness—Vinblastine—head and neck cancer	0.00388	0.00388	CcSEcCtD
Tadalafil—Urinary tract disorder—Docetaxel—head and neck cancer	0.00386	0.00386	CcSEcCtD
Tadalafil—Oedema peripheral—Docetaxel—head and neck cancer	0.00385	0.00385	CcSEcCtD
Tadalafil—Oedema—Fluorouracil—head and neck cancer	0.00385	0.00385	CcSEcCtD
Tadalafil—Connective tissue disorder—Docetaxel—head and neck cancer	0.00385	0.00385	CcSEcCtD
Tadalafil—Asthenia—Hydroxyurea—head and neck cancer	0.00384	0.00384	CcSEcCtD
Tadalafil—Urethral disorder—Docetaxel—head and neck cancer	0.00384	0.00384	CcSEcCtD
Tadalafil—Infection—Fluorouracil—head and neck cancer	0.00383	0.00383	CcSEcCtD
Tadalafil—Nervous system disorder—Fluorouracil—head and neck cancer	0.00378	0.00378	CcSEcCtD
Tadalafil—Tachycardia—Fluorouracil—head and neck cancer	0.00376	0.00376	CcSEcCtD
Tadalafil—Vomiting—Vinblastine—head and neck cancer	0.00373	0.00373	CcSEcCtD
Tadalafil—Erythema multiforme—Docetaxel—head and neck cancer	0.0037	0.0037	CcSEcCtD
Tadalafil—Headache—Vinblastine—head and neck cancer	0.00368	0.00368	CcSEcCtD
Tadalafil—Diarrhoea—Hydroxyurea—head and neck cancer	0.00366	0.00366	CcSEcCtD
Tadalafil—Eye disorder—Docetaxel—head and neck cancer	0.00366	0.00366	CcSEcCtD
Tadalafil—Cardiac disorder—Docetaxel—head and neck cancer	0.00363	0.00363	CcSEcCtD
Tadalafil—Flushing—Docetaxel—head and neck cancer	0.00363	0.00363	CcSEcCtD
Tadalafil—Hypotension—Fluorouracil—head and neck cancer	0.0036	0.0036	CcSEcCtD
Tadalafil—Angiopathy—Docetaxel—head and neck cancer	0.00355	0.00355	CcSEcCtD
Tadalafil—Dizziness—Hydroxyurea—head and neck cancer	0.00354	0.00354	CcSEcCtD
Tadalafil—Immune system disorder—Docetaxel—head and neck cancer	0.00353	0.00353	CcSEcCtD
Tadalafil—Mediastinal disorder—Docetaxel—head and neck cancer	0.00353	0.00353	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00351	0.00351	CcSEcCtD
Tadalafil—Nausea—Vinblastine—head and neck cancer	0.00349	0.00349	CcSEcCtD
Tadalafil—Insomnia—Fluorouracil—head and neck cancer	0.00348	0.00348	CcSEcCtD
Tadalafil—Paraesthesia—Fluorouracil—head and neck cancer	0.00346	0.00346	CcSEcCtD
Tadalafil—Dyspnoea—Fluorouracil—head and neck cancer	0.00343	0.00343	CcSEcCtD
Tadalafil—Mental disorder—Docetaxel—head and neck cancer	0.00343	0.00343	CcSEcCtD
Tadalafil—Somnolence—Fluorouracil—head and neck cancer	0.00342	0.00342	CcSEcCtD
Tadalafil—Vomiting—Hydroxyurea—head and neck cancer	0.0034	0.0034	CcSEcCtD
Tadalafil—Dyspepsia—Fluorouracil—head and neck cancer	0.00339	0.00339	CcSEcCtD
Tadalafil—Rash—Hydroxyurea—head and neck cancer	0.00337	0.00337	CcSEcCtD
Tadalafil—Dermatitis—Hydroxyurea—head and neck cancer	0.00337	0.00337	CcSEcCtD
Tadalafil—Headache—Hydroxyurea—head and neck cancer	0.00335	0.00335	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00333	0.00333	CcSEcCtD
Tadalafil—Back pain—Docetaxel—head and neck cancer	0.00329	0.00329	CcSEcCtD
Tadalafil—Pain—Fluorouracil—head and neck cancer	0.00329	0.00329	CcSEcCtD
Tadalafil—Muscle spasms—Docetaxel—head and neck cancer	0.00327	0.00327	CcSEcCtD
Tadalafil—Nausea—Hydroxyurea—head and neck cancer	0.00318	0.00318	CcSEcCtD
Tadalafil—Urticaria—Fluorouracil—head and neck cancer	0.00306	0.00306	CcSEcCtD
Tadalafil—Syncope—Docetaxel—head and neck cancer	0.00305	0.00305	CcSEcCtD
Tadalafil—Palpitations—Docetaxel—head and neck cancer	0.00301	0.00301	CcSEcCtD
Tadalafil—Loss of consciousness—Docetaxel—head and neck cancer	0.00299	0.00299	CcSEcCtD
Tadalafil—Cough—Docetaxel—head and neck cancer	0.00297	0.00297	CcSEcCtD
Tadalafil—Convulsion—Docetaxel—head and neck cancer	0.00295	0.00295	CcSEcCtD
Tadalafil—Hypertension—Docetaxel—head and neck cancer	0.00294	0.00294	CcSEcCtD
Tadalafil—Myalgia—Docetaxel—head and neck cancer	0.0029	0.0029	CcSEcCtD
Tadalafil—Arthralgia—Docetaxel—head and neck cancer	0.0029	0.0029	CcSEcCtD
Tadalafil—Chest pain—Docetaxel—head and neck cancer	0.0029	0.0029	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00288	0.00288	CcSEcCtD
Tadalafil—Hypersensitivity—Fluorouracil—head and neck cancer	0.00284	0.00284	CcSEcCtD
Tadalafil—Dry mouth—Docetaxel—head and neck cancer	0.00284	0.00284	CcSEcCtD
Tadalafil—Oedema—Docetaxel—head and neck cancer	0.00278	0.00278	CcSEcCtD
Tadalafil—Infection—Docetaxel—head and neck cancer	0.00276	0.00276	CcSEcCtD
Tadalafil—Shock—Docetaxel—head and neck cancer	0.00274	0.00274	CcSEcCtD
Tadalafil—Nervous system disorder—Docetaxel—head and neck cancer	0.00273	0.00273	CcSEcCtD
Tadalafil—Pruritus—Fluorouracil—head and neck cancer	0.00273	0.00273	CcSEcCtD
Tadalafil—Tachycardia—Docetaxel—head and neck cancer	0.00271	0.00271	CcSEcCtD
Tadalafil—Skin disorder—Docetaxel—head and neck cancer	0.0027	0.0027	CcSEcCtD
Tadalafil—Diarrhoea—Fluorouracil—head and neck cancer	0.00264	0.00264	CcSEcCtD
Tadalafil—Hypotension—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Tadalafil—Dizziness—Fluorouracil—head and neck cancer	0.00255	0.00255	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00253	0.00253	CcSEcCtD
Tadalafil—Insomnia—Docetaxel—head and neck cancer	0.00251	0.00251	CcSEcCtD
Tadalafil—Paraesthesia—Docetaxel—head and neck cancer	0.0025	0.0025	CcSEcCtD
Tadalafil—Dyspnoea—Docetaxel—head and neck cancer	0.00248	0.00248	CcSEcCtD
Tadalafil—Somnolence—Docetaxel—head and neck cancer	0.00247	0.00247	CcSEcCtD
Tadalafil—Vomiting—Fluorouracil—head and neck cancer	0.00245	0.00245	CcSEcCtD
Tadalafil—Dyspepsia—Docetaxel—head and neck cancer	0.00245	0.00245	CcSEcCtD
Tadalafil—Rash—Fluorouracil—head and neck cancer	0.00243	0.00243	CcSEcCtD
Tadalafil—Dermatitis—Fluorouracil—head and neck cancer	0.00243	0.00243	CcSEcCtD
Tadalafil—Headache—Fluorouracil—head and neck cancer	0.00241	0.00241	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.0024	0.0024	CcSEcCtD
Tadalafil—Fatigue—Docetaxel—head and neck cancer	0.0024	0.0024	CcSEcCtD
Tadalafil—Pain—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Tadalafil—Constipation—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Tadalafil—Nausea—Fluorouracil—head and neck cancer	0.00229	0.00229	CcSEcCtD
Tadalafil—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00227	0.00227	CcSEcCtD
Tadalafil—Abdominal pain—Docetaxel—head and neck cancer	0.0022	0.0022	CcSEcCtD
Tadalafil—Hypersensitivity—Docetaxel—head and neck cancer	0.00205	0.00205	CcSEcCtD
Tadalafil—Asthenia—Docetaxel—head and neck cancer	0.00199	0.00199	CcSEcCtD
Tadalafil—Pruritus—Docetaxel—head and neck cancer	0.00197	0.00197	CcSEcCtD
Tadalafil—Diarrhoea—Docetaxel—head and neck cancer	0.0019	0.0019	CcSEcCtD
Tadalafil—Dizziness—Docetaxel—head and neck cancer	0.00184	0.00184	CcSEcCtD
Tadalafil—Vomiting—Docetaxel—head and neck cancer	0.00177	0.00177	CcSEcCtD
Tadalafil—Rash—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Tadalafil—Dermatitis—Docetaxel—head and neck cancer	0.00175	0.00175	CcSEcCtD
Tadalafil—Headache—Docetaxel—head and neck cancer	0.00174	0.00174	CcSEcCtD
Tadalafil—Nausea—Docetaxel—head and neck cancer	0.00165	0.00165	CcSEcCtD
